IDEXX Laboratories Inc (IDXX)
494.22
+4.98
(+1.02%)
USD |
NASDAQ |
Apr 26, 09:56
IDEXX Laboratories Cash from Operations (TTM): 906.51M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 906.51M |
| September 30, 2023 | 830.09M |
| June 30, 2023 | 746.65M |
| March 31, 2023 | 612.19M |
| December 31, 2022 | 542.98M |
| September 30, 2022 | 579.52M |
| June 30, 2022 | 577.72M |
| March 31, 2022 | 745.83M |
| December 31, 2021 | 755.55M |
| September 30, 2021 | 764.52M |
| June 30, 2021 | 770.43M |
| March 31, 2021 | 744.61M |
| December 31, 2020 | 648.06M |
| September 30, 2020 | 584.54M |
| June 30, 2020 | 523.69M |
| March 31, 2020 | 452.65M |
| December 31, 2019 | 459.16M |
| September 30, 2019 | 439.39M |
| June 30, 2019 | 417.84M |
| March 31, 2019 | 399.56M |
| December 31, 2018 | 400.08M |
| September 30, 2018 | 385.56M |
| June 30, 2018 | 385.54M |
| March 31, 2018 | 376.90M |
| December 31, 2017 | 373.28M |
| Date | Value |
|---|---|
| September 30, 2017 | 352.90M |
| June 30, 2017 | 342.54M |
| March 31, 2017 | 343.23M |
| December 31, 2016 | 338.94M |
| September 30, 2016 | 317.52M |
| June 30, 2016 | 294.15M |
| March 31, 2016 | 263.44M |
| December 31, 2015 | 221.80M |
| September 30, 2015 | 169.77M |
| June 30, 2015 | 186.09M |
| March 31, 2015 | 187.68M |
| December 31, 2014 | 235.85M |
| September 30, 2014 | 273.96M |
| June 30, 2014 | 258.79M |
| March 31, 2014 | 258.46M |
| December 31, 2013 | 246.00M |
| September 30, 2013 | 249.50M |
| June 30, 2013 | 246.09M |
| March 31, 2013 | 228.28M |
| December 31, 2012 | 222.41M |
| September 30, 2012 | 207.88M |
| June 30, 2012 | 208.40M |
| March 31, 2012 | 207.88M |
| December 31, 2011 | 217.91M |
| September 30, 2011 | 212.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
417.84M
Minimum
Jun 2019
906.51M
Maximum
Dec 2023
636.94M
Average
612.19M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| Stryker Corp | 3.711B |
| Haemonetics Corp | 197.28M |
| Align Technology Inc | 785.78M |
| Edwards Lifesciences Corp | 895.80M |
| ACADIA Pharmaceuticals Inc | 16.70M |